STOCK TITAN

Argan Inc (AGX) director sells 4,556 shares in open-market trade

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Argan Inc. director Jeffrey John Ronald Jr. reported an open-market sale of the company’s common stock. On March 31, 2026, he sold 4,556 shares at an average price of $539.85 per share, according to the filing footnote.

After this transaction, he directly holds 3,636 shares of Argan common stock and has an additional 8,000 shares held indirectly through an IRA account listed as “John R. Jeffrey, IRA.” No derivative securities are reported as outstanding in this filing.

Positive

  • None.

Negative

  • None.
Insider Jeffrey John Ronald Jr.
Role Director
Sold 4,556 shs ($2.46M)
Type Security Shares Price Value
Sale Common Stock 4,556 $539.85 $2.46M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 3,636 shares (Direct); Common Stock — 8,000 shares (Indirect, John R. Jeffrey, IRA)
Footnotes (1)
  1. [object Object]
Shares sold 4,556 shares Open-market sale on March 31, 2026
Average sale price $539.85 per share Common Stock, open-market transaction
Direct holdings after sale 3,636 shares Total shares following transaction, direct ownership
Indirect IRA holdings 8,000 shares Held via “John R. Jeffrey, IRA”
Net shares sold 4,556 shares Net buy/sell shares in transaction summary
open-market sale financial
"sold 4,556 shares of the Issuer's common stock on the open market at an average price"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"On March 31, 2026, the Reporting Person sold 4,556 shares of the Issuer's common stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect financial
"total_shares_following_transaction": "8000.0000", "direct_or_indirect": "I""
IRA financial
"nature_of_ownership": "John R. Jeffrey, IRA""
An individual retirement account (IRA) is a savings account designed to help people put aside money for their retirement, often with tax advantages that encourage long-term savings. It matters to investors because it can grow over time, providing financial security later in life, and offers benefits that can reduce current taxes or allow investments to compound more effectively.
transaction code "S" financial
"transaction_code": "S", "transaction_code_description": "Sale in open market or private transaction""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jeffrey John Ronald Jr.

(Last)(First)(Middle)
C/O ARGAN, INC.
4075 WILSON BOULEVARD, SUITE 440

(Street)
ARLINGTON VIRGINIA 22203

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026S4,556(1)D$539.853,636D
Common Stock8,000IJohn R. Jeffrey, IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On March 31, 2026, the Reporting Person sold 4,556 shares of the Issuer's common stock on the open market at an average price of $539.85 per share.
/s/ John R. Jeffrey, Jr.04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Argan Inc (AGX) disclose in this Form 4?

Argan Inc reported that director Jeffrey John Ronald Jr. sold 4,556 shares of common stock in an open-market transaction at an average price of $539.85 per share on March 31, 2026, as detailed in the Form 4 filing footnote.

How many Argan Inc (AGX) shares did the director sell and at what price?

The director sold 4,556 shares of Argan Inc common stock at an average price of $539.85 per share. This was an open-market transaction executed on March 31, 2026, according to the Form 4 transaction data and accompanying footnote.

What are Jeffrey John Ronald Jr.’s remaining direct holdings in Argan Inc (AGX)?

Following the March 31, 2026 open-market sale, Jeffrey John Ronald Jr. directly holds 3,636 shares of Argan Inc common stock. This post-transaction balance is reported in the Form 4 as the total shares following the transaction for his direct ownership.

Does the Argan Inc (AGX) director have any indirect holdings after the sale?

Yes. In addition to his direct holdings, the Form 4 shows 8,000 Argan Inc common shares held indirectly through an account labeled “John R. Jeffrey, IRA.” This indirect position is reported as a holding entry with indirect ownership status.

Were any derivative securities reported for Argan Inc (AGX) in this Form 4?

No derivative securities were reported in this Form 4. The derivativeSummary section is empty, indicating there are no outstanding options, warrants, or other derivative positions disclosed for the reporting person in this particular filing.

Was the Argan Inc (AGX) insider transaction classified as a buy or sell?

The transaction was classified as a sell. The Form 4 identifies a transaction code “S,” describes it as an open-market sale, and marks the transaction_direction as “sell,” confirming that shares were disposed of rather than acquired.